Pillstats
Rx only · Tablet · Oral

Clopidogrel Bisulfate

Brands: Clopidogrel · Clopidogrel Bisulfate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)32968
US makers3 labelers
Packages7
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.016$0.032$0.049$0.065Dec 2025Apr 2026Jul 2026
$0.047
Latest avg · Jul 22, 2026
-17%
Since Dec 17, 2025
3
Active US suppliers
86%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

10K20K30K40K2025 Q12025 Q22025 Q32025 Q42026 Q1
27K
Rx · 2026 Q1
1.1M
Units dispensed
+52%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
A-S Medication Solutionsunknown3SUPPLYING
Ascend Laboratories, LLCunknown3SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.